LOGIN
No Improvement in Dysphasia Outcomes with Bupivacaine HCl in Anterior Cervical Discectomy & Fusion
March 2021
No Improvement in Dysphasia Outcomes with Bupivacaine HCl in Anterior Cervical Discectomy & Fusion
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1
Local Retropharyngeal Space Anesthetic for Dysphagia Reduction after Anterior Cervical Discectomy and Fusion Surgery: A Single-Center, Prospective, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial
World Neurosurg. 2021 Feb;146: e1377-e1383.Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
Synopsis
One hundred and twenty patients undergoing 1- or 2-level anterior cervical discectomy and fusion (ACDF) surgery for treatment of cervical degenerative disc disease with disc herniation, radiculopathy, and/or myelopathy symptoms were randomized to receive a 0.5% bupivacaine hydrochloride solution or 0.9% NaCl normal saline solution which was injected into the retropharyngeal space. Primary outcomes...
To view the full content, login to your account,
or start your 30-day FREE Trial today.
FREE TRIAL
LOGIN
Forgot Password?
Explore some of our unlocked ACE Reports below!
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.
Continue
Join the Conversation
Please Login or Join to leave comments.